One key mechanism underlying PDLIM2’s tumor-suppressive effects involves the negative regulation of the nuclear factor kappa B (NF-κB) and signal transducer and activator of transcription 3 (STAT3) signaling pathways [8–15,19–21]. Here, PDLIM2 is linked to neoplasm.